Developing therapies for the treatment of eye disease
EIR Biopharma, Inc. is an early-stage privately held biotech company developing therapeutics for the treatment of eye disease. We have partnered with the University of Miami’s Bascom Eye Institute for the treatment of glaucoma, and the Weill Cornell Medical College of Cornell University for the treatment of atrophic “dry” age-related macular degeneration. The founders have over 50 years of senior-level management experience in the biotechnology, pharmaceutical, and biopharma industries, and have helped to create publicly traded biopharma companies with peak market capitalizations exceeding $15 billion.
